BUY Piramal Pharma Limited — Rakesh Bansal
byRakesh BansalHorizon: NA (inferred Intraday)24 Sept 2026, 9:38 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · 3d ago
Piramal Pharma earns ‘Leader’ ESG rating from independent assessor
NewsGoogle News·18 Sept · 5d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Shrikant Chouhan, Kotak Securities9 Nov 2026 · ~1 year · target ₹310 · Active
- BUY — Shrikant Chouhan, Kotak Securities6 Nov 2026 · ~2 weeks · target ₹250 · Target hit
- BUY — Amol Athawale, Kotak Securities4 Nov 2026 · ~3 months · target ₹270 · Active
- BUY — Rakesh Bansal2 Nov 2026 · ~2 weeks · target ₹267 · Active
- BUY — Kunal Saraogi30 Oct 2026 · ~1 year · target ₹300 · Active
More from Rakesh Bansal
- BUY Agi Infra13 Nov 2026 · ~3 months · target ₹360 · Active
- BUY Reliance Industries13 Nov 2026 · Next day · target ₹1,375 · Active
- BUY Hero MotoCorp13 Nov 2026 · ~2 weeks · target ₹5,497 · Active
- BUY Edelweiss Financial Services13 Nov 2026 · ~2 weeks · target ₹147 · Active
- BUY Dalmia Bharat Sugar and Industries13 Nov 2026 · ~2 weeks · target ₹550 · Active

